IDSA 2014 Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections Original paper

What was reviewed?

This guideline reviewed the diagnosis, microbial causes, and treatment strategies for skin and soft tissue infections (SSTIs), including superficial infections, abscesses, cellulitis, necrotizing fasciitis, clostridial myonecrosis, and infections affecting immunocompromised patients. The guideline identified that SSTIs arise when microbiome or environmental microbes breach the skin barrier, allowing colonizing or pathogenic organisms such as Staphylococcus aureus, Streptococcus pyogenes, and Clostridium perfringens to invade deeper tissue layers. It emphasized that microbiome-derived anaerobic organisms, including clostridial species, play a central role in necrotizing infections such as gas gangrene and myonecrosis. These infections are driven by toxin-producing anaerobic bacteria that proliferate under hypoxic conditions and rapidly destroy tissue. The guideline also emphasized the importance of identifying microbiome-derived polymicrobial infections, particularly those involving anaerobes and facultative pathogens, as these infections require broader antimicrobial coverage and surgical intervention. The review integrated clinical evidence using systematic evaluation and grading of microbiological and treatment outcomes to define evidence-based approaches for identifying microbiome-associated infection patterns and optimizing therapeutic interventions.

Who was reviewed?

The guideline reviewed clinical data from diverse patient populations, including immunocompetent individuals, immunocompromised patients, surgical patients, trauma patients, and individuals with recurrent or severe infections involving microbiome-derived pathogens. These populations represented hosts with varying microbiome disruption levels, including those with diabetes, immune suppression, prior antibiotic exposure, surgical wounds, and skin barrier damage. The guideline also reviewed infections caused by microbiome-associated pathogens such as Staphylococcus aureus, Streptococcus pyogenes, gram-negative enteric bacteria, anaerobic clostridial species, and polymicrobial communities originating from the gut or skin microbiome. These microbes represent both commensal organisms and opportunistic pathogens that can transition into invasive disease when host defenses weaken. The reviewed cases demonstrated that microbiome composition, antibiotic exposure, and immune dysfunction strongly influence infection risk, pathogen selection, and treatment response.

What were the most important findings?

The most important finding was that microbiome-derived bacteria serve as the primary source of skin and soft tissue infections, with pathogenic transition occurring when host barriers and immune defenses weaken. Major microbial associations included overgrowth of Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), which frequently colonize the skin microbiome and cause abscesses and cellulitis. Beta-hemolytic streptococci represented another major association, causing rapidly spreading infections following skin barrier disruption. Critically, anaerobic microbiome organisms such as Clostridium perfringens were strongly associated with necrotizing infections, including gas gangrene and myonecrosis, where toxin production caused rapid tissue destruction, systemic inflammation, and high mortality risk. The guideline emphasized that microbiome polymicrobial communities, including anaerobes and facultative bacteria, frequently cause severe infections, especially in surgical wounds, diabetic tissue, and necrotic environments. Antibiotic resistance emerged as a major microbiome-associated factor influencing treatment success, particularly resistance among MRSA and anaerobic pathogens. The findings also confirmed that microbiome disruption from antibiotic exposure, immune suppression, trauma, or surgical intervention increases susceptibility to invasive infections by enabling pathogenic expansion of opportunistic microbiome species.

What are the greatest implications of this review?

This guideline demonstrated that SSTIs represent a direct clinical manifestation of microbiome imbalance, barrier disruption, and opportunistic pathogen expansion. The identification of microbiome-derived organisms such as MRSA and Clostridium perfringens as dominant causes of severe infections reinforces the importance of microbiome surveillance, targeted antimicrobial therapy, and early surgical intervention. These findings confirm that microbiome stability plays a critical protective role in preventing invasive infection, while microbiome disruption increases susceptibility to severe and treatment-resistant disease. Clinically, microbiome signatures such as MRSA colonization, anaerobic bacterial presence, and polymicrobial infection patterns provide important diagnostic and prognostic markers. These findings also highlight the importance of preserving microbiome integrity, minimizing unnecessary antibiotic exposure, and rapidly identifying toxin-producing anaerobes to prevent progression to life-threatening infections such as necrotizing fasciitis and gas gangrene.